Venetoclax-Ibrutinib Combinations as First-Line Therapy in Chronic Lymphocytic Leukemia: A Meta-Analysis of Randomized Controlled Trials with GRADE Approach


TANRIVERDİ L. H., SARICI A.

Archives of Basic and Clinical Research, cilt.8, sa.1, ss.7-19, 2026 (TRDizin)